Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Podofilox is a topical agent used for the treatment of external genital warts and perianal warts. A lignan found in podophyllin resin from the roots of podophyllum plants.
- Mechanism
- Curator reviewed
The exact mechanism of action is not well understood. It does appear, however, that it and its derivatives may bind and inhibit topoisomerase II during the late S and early G2 stage. The drug may bind and stabilize the temporary break caused by the enzyme. This disrupts the reparation of the break through which the double-stranded DNA passes, and consequently stops DNA unwinding and replication
- Primary indication
- For treatment of external genital warts (Condyloma acuminatum).Curator reviewed · 3 structured indications
- Formula / weight
- C22H22O8 · 414.4053 g/mol (avg)
- First approval
- Canada, 2000 · United States, 1990
- Also known as
- Podophyllotoxin
- Brand names
- Condylox
Resolves to
YJGVMLPVUAXIQN-XVVDYKMHSA-NSMILES[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Podofilox, and which of those have an active Phase 3 trial?